The Construction and Visualization of the Transmission Networks for COVID-19: A Potential Solution for Contact Tracing and Assessments of Epidemics
Authors
Affiliations
The WHO has described coronavirus disease 2019 (COVID-19) as a pandemic due to the speed and scale of its transmission. Without effective interventions, the rapidly increasing number of COVID-19 cases would greatly increase the burden of clinical treatments. Identifying the transmission sources and pathways is of vital importance to block transmission and allocate limited public health resources. According to the relationships among cases, we constructed disease transmission network graphs for the COVID-19 epidemic through a visualization technique based on individual reports of epidemiological data. We proposed an analysis strategy of the transmission network with the epidemiological data in Tianjin and Chengdu. The transmission networks showed different transmission characteristics. In Tianjin, an imported case of COVID-19 can produce an average of 2.9 secondary infections and ultimately produce as many as 4 generations of infections, with a maximum of 6 cases being generated before the imported case is identified. In Chengdu, 45 noninformative cases and 24 cases with vague exposure information made accurate information about the transmission network difficult to provide. The proposed analysis framework of visualized transmission networks can trace the transmission source and contacts, assess the current situation of transmission and prevention, and provide evidence for the global response and control of the COVID-19 pandemic.
Understanding epidemic spread patterns: a visual analysis approach.
Wu J, Niu Z, Liu X Health Syst (Basingstoke). 2024; 13(3):229-245.
PMID: 39175497 PMC: 11338210. DOI: 10.1080/20476965.2024.2308286.
Zhang L, Guo W, Lv C Sci One Health. 2024; 3:100061.
PMID: 39077381 PMC: 11262286. DOI: 10.1016/j.soh.2023.100061.
Lee H, Choi H, Lee H, Lee S, Kim C Front Public Health. 2024; 12:1362823.
PMID: 38887240 PMC: 11180726. DOI: 10.3389/fpubh.2024.1362823.
Zhang C, Hu W, Li Y, Lv Y, Zhang S Hum Vaccin Immunother. 2023; 19(2):2251826.
PMID: 37665634 PMC: 10478737. DOI: 10.1080/21645515.2023.2251826.
Risk factors of infection among close contacts of COVID-19: A systematic review and meta-analysis.
Gao C, Jiang J, Mao J, Yu X, Zheng X, Zhang J Medicine (Baltimore). 2023; 102(29):e34314.
PMID: 37478226 PMC: 10662811. DOI: 10.1097/MD.0000000000034314.